4//SEC Filing
Inglis Tiffany Eul Davis 4
Accession 0001193125-25-240530
CIK 0001534969other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 7:12 PM ET
Size
7.5 KB
Accession
0001193125-25-240530
Insider Transaction Report
Form 4
Inglis Tiffany Eul Davis
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-10-15+107,000→ 107,000 totalExercise: $3.13Exp: 2035-10-15→ Class A Common Stock (107,000 underlying) - Award
Class A Common Stock
2025-10-15+75,000→ 75,000 total
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is October 10, 2025, and 1/12 of the remaining amount vests in quarterly installments for three years thereafter, subject to the Reporting Person continuing to provide services to the issuer.
- [F2]These stock options vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is October 10, 2025, and 1/36 of the remaining amount vests in monthly installments for three years thereafter, subject to the Reporting Person continuing to provide services to the issuer.
Documents
Issuer
SERA PROGNOSTICS, INC.
CIK 0001534969
Entity typeother
Related Parties
1- filerCIK 0002091798
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 7:12 PM ET
- Size
- 7.5 KB